0001104659-23-033350.txt : 20230316 0001104659-23-033350.hdr.sgml : 20230316 20230316163653 ACCESSION NUMBER: 0001104659-23-033350 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellectar Biosciences, Inc. CENTRAL INDEX KEY: 0001279704 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043321804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36598 FILM NUMBER: 23739362 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (608) 441-8120 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: NOVELOS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050617 FORMER COMPANY: FORMER CONFORMED NAME: COMMON HORIZONS INC DATE OF NAME CHANGE: 20040211 10-K/A 1 tm239725d1_10ka.htm FORM 10-K/A
0001279704 false --12-31 2022 FY 0001279704 2022-01-01 2022-12-31 0001279704 2022-06-30 0001279704 2023-03-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

Amendment No. 1

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from  ______ to ______

 

Commission File Number 333-119366

 

CELLECTAR BIOSCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   04-3321804

(State or other jurisdiction of

incorporation or organization)

  

(IRS Employer

Identification Number)

   

100 Campus Drive

Florham Park, New Jersey

   07932
(Address of principal executive offices)   (Zip Code)

 

(608) 441-8120

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class  

Trading

Symbol(s)

  

Name of Each Exchange

on Which Registered

Common Stock, par value $0.00001   CLRB   Nasdaq Capital Market

 

Securities registered pursuant to Section 12(g) of the Act:
None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.     Yes  ¨    No  x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes   ¨      No  x

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes   x      No  ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes   x      No   ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.    Yes      No

 

Large accelerated filer  ¨     Accelerated filer ¨  
       
Non-accelerated filer    x   Smaller reporting company x
       
    Emerging growth company ¨  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ¨

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.    ¨

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.    ¨

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).   ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes   ¨     No   x

 

The aggregate market value of the registrant’s voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of June 30, 2022, was $24,322,264.

 

As of March 3, 2023, there were 9,740,507 shares of the registrant’s $0.0001 par value common stock outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the registrant's definitive proxy statement for the registrant's 2023 Annual Meeting of Stockholders are incorporated by reference in Part III of the annual report on Form 10-K. The definitive proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year covered by the annual report on Form 10-K.

 

Auditor Name   Auditor Location   Auditor Firm ID
Baker Tilly US, LLP   Philadelphia, PA   23

 

 

 

 

 

EXPLANATORY NOTE

 

This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) is being filed to amend our Annual Report on Form 10-K for the year ended December 31, 2022 (the “Original Filing”), filed with the U.S. Securities and Exchange Commission on March 9, 2023 (the “Original Filing Date”). The sole purpose of this Amendment No. 1 is to append Exhibits 3.9, 3.10, 10.18, 10.19, 10.29, 10.30, 10.31, and 10.32, which were inadvertently omitted from the Original Filing, and to correct Exhibit 3.11 of the Original Filing. Except as described above, no changes have been made to the Original Filing and this Amendment No. 1 does not modify, amend or update in any way any of the financial or other information contained in the Original Filing. Part IV of the Original Filing is also amended to add new certifications in accordance with Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

 

 

 

PART IV

 

Item 15.Exhibits, Financial Statement Schedules.

 

(a)Documents filed with this annual report on Form 10-K.

 

(1) Financial Statements

 

i.All financial statements of the Company as set forth under Item 8 of the Original Filing.

 

(2) Exhibits – The exhibits to this annual report on Form 10-K are listed on the Exhibit Index below.

 

 

 

EXHIBIT INDEX

 

      Incorporated by Reference
Exhibit
No.		  Description  Form  Filing Date  Exhibit
No.
2.1  Agreement and Plan of Merger by and among Novelos Therapeutics, Inc., Cell Acquisition Corp. and Cellectar, Inc. dated April 8, 2011  8-K  April 11, 2011  2.1
3.1  Second Amended and Restated Certificate of Incorporation  8-K  April 11, 2011  3.1
3.2  Certificate of Ownership and Merger of Cellectar Biosciences, Inc. with and into Novelos Therapeutics, Inc.  8-K  February 13, 2014  3.1
3.3  Certificate of Amendment to Second Amended and Restated Certificate of Incorporation  8-K  June 13, 2014  3.1
3.4  Certificate of Amendment to Second Amended and Restated Certificate of Incorporation  8-K  June 19, 2015  3.2
3.5  Certificate of Amendment to Second Amended and Restated Certificate of Incorporation  8-K  March 4, 2016  3.1
3.6  Certificate of Amendment to Second Amended and Restated Certificate of Incorporation  8-K  June 1, 2017  3.2
3.7  Certificate of Amendment of Second Amended and Restated Certificate of Incorporation  8-K  July 13, 2018  3.1
3.8  Certificate of Amendment of Second Amended and Restated Certificate of Incorporation  8-K  February 25, 2021  3.1
3.9  Certificate of Correction of Certificate of Amendment of Second Amended and Restated Certificate of Incorporation  10-Q  May 10, 2022  3.1
3.10  Certificate of Amendment to Second Amended and Restated Certificate of Incorporation  8-K  July 21, 2022  3.1
3.11  Amended and Restated By-laws  8-K  November 29, 2022  3.1
3.12  Form of Certificate of Designation of Series C Preferred Stock  S-1/A  July 18, 2018  3.11
3.13  Form of Certificate of Designation of Series D Preferred Stock certificate  8-K  December 28, 2020  3.1
4.1  Form of common stock certificate  S-1/A  November 9, 2011  4.1
4.2  Form of Series D Preferred Stock certificate  8-K  December 28, 2020  4.1
4.3*  Description of Securities Registered under Section 12(b) of the Securities Exchange Act of 1934  ​  ​  ​
10.1  Form of Restricted Common Stock Agreement**  10-Q  August 14, 2017  10.1
10.2  Form of Series D Common Stock Purchase Warrant  8-K  October 11, 2017  4.1

 

 

 

10.3  Registration Rights Agreement, dated as of October 10, 2017, by and among Cellectar Biosciences, Inc. and the Purchasers  8-K  October 11, 2017  10.2
10.4  Form of Non-Statutory Stock Option**  S-8  November 9, 2017  10.2
10.5  Stock Option Agreement with James V. Caruso**  S-8  November 9, 2017  10.4
10.6  Stock Option Agreement with Jarrod Longcor**  S-8  November 9, 2017  10.5
10.7  Series E Common Stock Purchase Warrant  S-1/A  July 18, 2018  4.5
10.8  Form of Warrant Agency Agreement  S-1/A  July 18, 2018  4.7
10.9  Agreement of Lease between the Company and KBS II 100-200 Campus Drive, LLC  S-1/A  July 18, 2018  10.35
10.10  Form of Non-Statutory Stock Option (Definitive/Contingent – Employees)**  10-Q  November 13, 2018  10.3
10.11  Form of Non-Statutory Stock Option (Definitive/Contingent – Directors)**  10-Q  November 13, 2018  10.4
10.12  Amended and Restated Employment Agreement between the Company and James Caruso, dated April 15, 2019**  8-K  April 19, 2019  10.1
10.13  Amended and Restated Employment Agreement between the Company and Jarrod Longcor, dated April 15, 2019**  8-K  April 19, 2019  10.2
10.14  Form of Series F Common Stock Purchase Warrant  8-K  May 20, 2019  4.1
10.15  Form of Series G Common Stock Purchase Warrant  8-K  May 20, 2019  4.2
10.16  Registration Rights Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers  8-K  May 20, 2019  10.3
10.17  Cellectar Biosciences, Inc. Amended and Restated 2015 Stock Incentive Plan**  8-K  June 14, 2019  10.1
10.18  2021 Stock Incentive Plan**  8-K  June 24, 2021  10.1
10.19  Amendment 1 to the 2021 Stock Incentive Plan**  8-K  June 27, 2022  10.1
10.20  Amendment to Amended and Restated Employment Agreement between the Company and Jarrod Longcor dated November 10, 2019**  10-Q  November 12, 2019  10.2
10.21  Form of Underwriting Agreement  S-1/A  May 20, 2020  1.1
10.22  Form of Series H Warrant  S-1/A  May 20, 2020  4.3
10.23  Form of Warrant Agency Agreement  8-K  June 5, 2020  4.3

 

 

 

10.24  Equity Distribution Agreement between Cellectar Biosciences, Inc. and Oppenheimer & Co. Inc., dated August 11, 2020  8-K  August 11, 2020  10.1
10.25  Form of Securities Purchase Agreement  8-K  December 28, 2020  10.1
10.26  Form of Registration Rights Agreement  8-K  December 28, 2020  10.2
10.27  Employment Agreement between the Company and Chad Kolean, dated February 23, 2022  8-K  February 25, 2022  10.1
10.28*  Form of First Amendment of Lease, dated December 30, 2022  8-K  January 4, 2023  ​
10.29  Form of Common Warrant  8-K  October 25, 2022 
10.30  Form of Pre-Funded Warrant  8-K  October 25, 2022 
10.31  Form of Registration Rights Agreement, dated as of October 20, 2022, by and between the Company and the purchasers named therein  8-K  October 25, 2022 
10.32  Form of Indemnification Agreement  8-K  December 2, 2022 
21.1*  List of Subsidiaries         
23.1*  Consent of Independent Registered Public Accounting Firm (Baker Tilly US, LLP, Philadelphia, PA, PCAOB ID: 23)         
24.1*  Power of Attorney (included on the Signatures page of this Annual Report on Form 10-K)         
31.1  Certification of chief executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002         
31.2  Certification of chief financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002         
32.1*  Certification of chief executive officer and chief financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002         
101*  Interactive Data Files         
104*  Cover Page Interactive Data File  ​  ​  ​
             

 

*Previously filed with the Original Filing.
** Management contract or compensatory plan or arrangement.

 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused Amendment No. 1 to this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CELLECTAR BIOSCIENCES, INC.
     
  By: /s/ James V. Caruso
  James V. Caruso
  Title:  Chief Executive Officer
  March 16, 2023

 

 

 

 EX-31.1 2 tm239725d1_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, James V. Caruso, President and Chief Executive Officer, Cellectar Biosciences, Inc., certify that:

 

1.I have reviewed this Annual Report on Form 10-K of Cellectar Biosciences, Inc.; and

2.Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

  /s/ James V. Caruso
Date: March 16, 2023 James V. Caruso
  President and Chief Executive Officer

 

 EX-31.2 3 tm239725d1_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Chad J. Kolean, Chief Financial Officer, Cellectar Biosciences, Inc., certify that:

 

  1. I have reviewed this Annual Report on Form 10-K of Cellectar Biosciences, Inc.; and

  2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

  /s/ Chad J. Kolean
Date: March 16, 2023 Chad J. Kolean
  Chief Financial Officer

 

 EX-101.SCH 4 clrb-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 clrb-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Name Auditor Location Auditor Firm ID EX-101.PRE 6 clrb-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 03, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 333-119366    
Entity Registrant Name CELLECTAR BIOSCIENCES, INC.    
Entity Central Index Key 0001279704    
Entity Tax Identification Number 04-3321804    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 100 Campus Drive    
Entity Address, City or Town Florham Park    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 07932    
City Area Code 608    
Local Phone Number 441-8120    
Title of 12(b) Security Common Stock, par value $0.00001    
Trading Symbol CLRB    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 24,322,264
Entity Common Stock, Shares Outstanding   9,740,507  
ICFR Auditor Attestation Flag false    
Auditor Name Baker Tilly US, LLP    
Auditor Location Philadelphia, PA    
Auditor Firm ID 23    
XML 8 tm239725d1_10ka_htm.xml IDEA: XBRL DOCUMENT 0001279704 2022-01-01 2022-12-31 0001279704 2022-06-30 0001279704 2023-03-03 iso4217:USD shares iso4217:USD shares 0001279704 false --12-31 2022 FY 10-K/A true 2022-12-31 false 333-119366 CELLECTAR BIOSCIENCES, INC. DE 04-3321804 100 Campus Drive Florham Park NJ 07932 608 441-8120 Common Stock, par value $0.00001 CLRB NASDAQ No No Yes Yes Non-accelerated Filer true false false false 24322264 9740507 Baker Tilly US, LLP Philadelphia, PA 23 EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 3 36 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://novelos.com/role/Cover Cover Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate - tm239725d1_10ka.htm 25 tm239725d1_10ka.htm clrb-20221231.xsd clrb-20221231_lab.xml clrb-20221231_pre.xml tm239725d1_ex31-1.htm tm239725d1_ex31-2.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm239725d1_10ka.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021q4": 36 }, "contextCount": 3, "dts": { "inline": { "local": [ "tm239725d1_10ka.htm" ] }, "labelLink": { "local": [ "clrb-20221231_lab.xml" ] }, "presentationLink": { "local": [ "clrb-20221231_pre.xml" ] }, "schema": { "local": [ "clrb-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 63, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 5, "total": 5 }, "keyCustom": 0, "keyStandard": 36, "memberCustom": 0, "memberStandard": 0, "nsprefix": "clrb", "nsuri": "http://novelos.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm239725d1_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://novelos.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm239725d1_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://novelos.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001104659-23-033350-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-033350-xbrl.zip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